Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
US Market
Holding INBP?
Track your performance easily

Integrated BioPharma (INBP) Financial Statements

8 Followers

Integrated BioPharma Financial Overview

Integrated BioPharma's market cap is currently ―. The company's EPS TTM is $0.003; its P/E ratio is 96.97; Integrated BioPharma is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 12.75M$ 13.15M$ 11.51M$ 12.91M$ 12.99M
Gross Profit$ 1.28M$ 1.25M$ 520.00K$ 832.00K$ 986.00K
EBIT$ 472.00K$ 356.00K$ -452.00K$ -54.00K$ 119.00K
EBITDA$ 789.00K$ 660.00K$ -452.00K$ 244.00K$ 418.00K
Net Income Common Stockholders$ 268.00K$ 285.00K$ -382.00K$ -59.00K$ 40.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.68M$ 2.02M$ 732.00K$ 2.59M$ 1.32M
Total Assets$ 26.21M$ 26.94M$ 25.72M$ 26.64M$ 25.43M
Total Debt$ 1.80M$ 2.04M$ 2.27M$ 2.51M$ 2.67M
Net Debt$ 121.00K$ 19.00K$ 1.54M$ -82.00K$ 1.36M
Total Liabilities$ 6.97M$ 8.03M$ 7.16M$ 7.76M$ 6.57M
Stockholders Equity$ 19.24M$ 18.91M$ 18.57M$ 18.89M$ 18.86M
Cash Flow-
Free Cash Flow$ -332.00K$ 1.30M$ -1.28M$ 1.27M$ -1.20M
Operating Cash Flow$ -186.00K$ 1.64M$ -1.31M$ 1.31M$ -1.19M
Investing Cash Flow$ -146.00K$ -345.00K$ 37.94K$ -38.00K$ -17.00K
Financing Cash Flow$ -11.00K$ -10.00K$ -3.01K$ 3.00K$ -10.00K
Currency in USD

Integrated BioPharma Earnings and Revenue History

Integrated BioPharma Debt to Assets

Integrated BioPharma Cash Flow

Integrated BioPharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis